Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

As Anti-corruption Crusader In India Is Booked On Corruption Charges, Analysts Wonder If There Are More Skeletons In The Closet

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Ketan Dhirajlal Desai, President of the Medical Council of India, has been grabbing headlines for the past several months for his efforts to implement a legally binding code of ethical practices among doctors in dealing with pharmaceutical companies that try to push their products. But the same man who assumed a moral high ground and tried to publicly spearhead a crusade against corruption has now landed up in a case of alleged bribery that also involves authorities from a medical college in Northern India

You may also be interested in...



After Strictures For Doctors, Medical Council of India Now Guns For Pharma Companies Offering Kickbacks

MUMBAI - The Medical Council of India - the governing body for medical education and practice in India - has proposed to the Indian health ministry that legal provisions be finalized to penalize pharmaceutical companies that offer expensive gifts, donations or travel reimbursement to doctors with an intention to generate higher sales for their brands

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

Latest Headlines
See All
UsernamePublicRestriction

Register

SC074646

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel